OnKure Therapeutics is based in Boulder, Colorado. It has raised $222M in total funding. Latest round: Growth.
OnKure Therapeutics funding overview
OnKure Therapeutics is based in Boulder, Colorado. OnKure Therapeutics has raised $222M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in October 2024. The round record for OnKure Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, New Enterprise Associates, Citadel, Deep Track, Perceptive, Acorn and 1 others. 7 distinct backers are named across the disclosed rounds.
OnKure Therapeutics at a glance
Total raised
$222M
Latest round
Growth
Latest round date
October 2024
Headquarters
Boulder, Colorado
Notable investors
Cormorant Asset Management, New Enterprise Associates, Citadel, Deep Track, Perceptive, Acorn, Samsara
Frequently asked about OnKure Therapeutics funding
How much has OnKure Therapeutics raised?
OnKure Therapeutics has raised $222M in total disclosed funding across the rounds on record.
Who has invested in OnKure Therapeutics?
Cormorant Asset Management, New Enterprise Associates, Citadel, Deep Track, Perceptive, Acorn are named among the investors backing OnKure Therapeutics.
What was the latest OnKure Therapeutics funding round?
The most recent disclosed round is a Growth, announced in October 2024.
Where is OnKure Therapeutics based?
OnKure Therapeutics is based in Boulder, Colorado.
When did OnKure Therapeutics last raise?
The last disclosed OnKure Therapeutics round closed in October 2024 at Growth.
Round data for OnKure Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boulder and backer lists below.
